Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Effects of inhibition of interleukin-6 signalling on insulin sensitivity and lipoprotein (a) levels in human subjects with rheumatoid diseases.

Schultz O, Oberhauser F, Saech J, Rubbert-Roth A, Hahn M, Krone W, Laudes M.

PLoS One. 2010 Dec 13;5(12):e14328. doi: 10.1371/journal.pone.0014328.

2.

Insulin resistance, inflammatory biomarkers, and adipokines in patients with chronic kidney disease: effects of angiotensin II blockade.

de Vinuesa SG, Goicoechea M, Kanter J, Puerta M, Cachofeiro V, Lahera V, Gómez-Campderá F, Luño J.

J Am Soc Nephrol. 2006 Dec;17(12 Suppl 3):S206-12.

3.

Hypovitaminosis D associations with adverse metabolic parameters are accentuated in patients with Type 2 diabetes mellitus: a body mass index-independent role of adiponectin?

Al-Daghri NM, Al-Attas OS, Alokail MS, Alkharfy KM, Al-Othman A, Draz HM, Yakout SM, Al-Saleh Y, Al-Yousef M, Sabico S, Clerici M, Chrousos GP.

J Endocrinol Invest. 2013 Jan;36(1):1-6. doi: 10.3275/8183. Epub 2011 Dec 15.

PMID:
22183134
4.

Insulin resistance and levels of adipokines in patients with untreated early rheumatoid arthritis.

Manrique-Arija S, Ureña I, Valdivielso P, Rioja J, Jiménez-Núñez FG, Irigoyen MV, Fernández-Nebro A.

Clin Rheumatol. 2016 Jan;35(1):43-53. doi: 10.1007/s10067-015-3106-8. Epub 2015 Nov 3.

5.

Effects of 90-day hypolipidemic treatment on insulin resistance, adipokines and proinflammatory cytokines in patients with mixed hyperlipidemia and impaired fasting glucose.

Buldak L, Dulawa-Buldak A, Labuzek K, Okopien B.

Int J Clin Pharmacol Ther. 2012 Nov;50(11):805-13. doi: 10.5414/CP201735.

PMID:
22943927
6.

Interleukin 6, adiponectin, leptin, and insulin resistance in nonobese Japanese type 2 diabetic patients.

Taniguchi A, Fukushima M, Ohya M, Nakai Y, Yoshii S, Nagasaka S, Matsumoto K, Taki Y, Kuroe A, Nishimura F, Seino Y.

Metabolism. 2006 Feb;55(2):258-62.

PMID:
16423635
7.

Relationship of adipokine to insulin sensitivity and glycemic regulation in obese women--the effect of body weight reduction by caloric restriction.

Golubović MV, Dimić D, Antić S, Radenković S, Djindjić B, Jovanović M.

Vojnosanit Pregl. 2013 Mar;70(3):284-91.

PMID:
23607240
8.

Changes in inflammatory and metabolic parameters after periodontal treatment in patients with and without obesity.

Altay U, Gürgan CA, Ağbaht K.

J Periodontol. 2013 Jan;84(1):13-23. doi: 10.1902/jop.2012.110646. Epub 2012 Feb 21.

PMID:
22348694
9.

The effect of abdominal obesity on insulin sensitivity and serum lipid and cytokine concentrations in African women.

Crowther NJ, Ferris WF, Ojwang PJ, Rheeder P.

Clin Endocrinol (Oxf). 2006 May;64(5):535-41.

PMID:
16649973
10.

Correlation between the adiponectin-leptin ratio and parameters of insulin resistance in patients with type 2 diabetes.

Inoue M, Maehata E, Yano M, Taniyama M, Suzuki S.

Metabolism. 2005 Mar;54(3):281-6.

PMID:
15736103
11.

Weight loss due to a very low calorie diet differentially affects insulin sensitivity and interleukin-6 serum levels in nondiabetic obese human subjects.

Oberhauser F, Schulte DM, Faust M, Güdelhöfer H, Hahn M, Müller N, Neumann K, Krone W, Laudes M.

Horm Metab Res. 2012 Jun;44(6):465-70. doi: 10.1055/s-0032-1306341. Epub 2012 Mar 21.

PMID:
22438213
12.

Relation of the rs6923761 gene variant in glucagon-like peptide 1 receptor with weight, cardiovascular risk factor, and serum adipokine levels in obese female subjects.

de Luis DA, Aller R, de la Fuente B, Primo D, Conde R, Izaola O, Sagrado MG.

J Clin Lab Anal. 2015 Mar;29(2):100-5. doi: 10.1002/jcla.21735. Epub 2014 Mar 28.

PMID:
24687535
13.

Recent advances in the relationship between obesity, inflammation, and insulin resistance.

Bastard JP, Maachi M, Lagathu C, Kim MJ, Caron M, Vidal H, Capeau J, Feve B.

Eur Cytokine Netw. 2006 Mar;17(1):4-12. Review.

14.
15.

Relationship between the adiponectin-leptin ratio and parameters of insulin resistance in subjects without hyperglycemia.

Inoue M, Yano M, Yamakado M, Maehata E, Suzuki S.

Metabolism. 2006 Sep;55(9):1248-54.

PMID:
16919546
16.

Effect of smoking habit on circulating adipokines in diabetic and non-diabetic subjects.

Al Mutairi SS, Mojiminiyi OA, Shihab-Eldeen AA, Al Sharafi A, Abdella N.

Ann Nutr Metab. 2008;52(4):329-34. doi: 10.1159/000151487. Epub 2008 Aug 19.

PMID:
18714151
17.

Effects of rosiglitazone/metformin fixed-dose combination therapy and metformin monotherapy on serum vaspin, adiponectin and IL-6 levels in drug-naïve patients with type 2 diabetes.

Kadoglou NP, Kapelouzou A, Tsanikidis H, Vitta I, Liapis CD, Sailer N.

Exp Clin Endocrinol Diabetes. 2011 Feb;119(2):63-8. doi: 10.1055/s-0030-1265174. Epub 2010 Oct 28.

PMID:
21031343
18.

Low circulating adiponectin levels are associated with insulin resistance in non-obese peritoneal dialysis patients.

Yoo DE, Lee MJ, Oh HJ, Kim SJ, Shin DH, Yoo TH, Kang SW, Choi KH, Han DS, Han SH.

Endocr J. 2012;59(8):685-95. Epub 2012 May 12.

19.

Adipokines influencing metabolic and cardiovascular disease are differentially regulated in maintenance hemodialysis.

Ziegelmeier M, Bachmann A, Seeger J, Lossner U, Kratzsch J, Blüher M, Stumvoll M, Fasshauer M.

Metabolism. 2008 Oct;57(10):1414-21. doi: 10.1016/j.metabol.2008.05.011.

PMID:
18803947
20.

Adipocytokines, insulin resistance, and coronary atherosclerosis in rheumatoid arthritis.

Rho YH, Chung CP, Solus JF, Raggi P, Oeser A, Gebretsadik T, Shintani A, Stein CM.

Arthritis Rheum. 2010 May;62(5):1259-64. doi: 10.1002/art.27376.

Supplemental Content

Support Center